Drawing for SIGHTSCORE

USPTO serial 79348078

SIGHTSCORE

Reviewed by CopyMark Law Group

Reg. 7204048Status 404
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
BLAKESLEE, RICHARD A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SIGHTSCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Reagents for medical or clinical testing in the nature of medical diagnostic reagents and assays for testing of bodily fluids; reagents for use in medical genetic testing; blood, buccal and saliva swabs and preserving reagents for collecting DNA samples for medical or clinical testing; reagents for use in diagnostic testing for medical purposes; diagnostic kits comprised primarily of test reagents for use in medical testing; diagnostic kits comprised primarily of test reagents for use in medical genetic testingSECTION 70 - CANCELLED—
009Downloadable computer software for analysing, reporting, screening and tracking data and information for use in the fields of health, medicine, pharmaceutical development, genetics, bioinformatics, ophthalmology, and eye health; downloadable computer software for collecting, analysing, reporting, screening and tracking data and information in the fields of health, medicine, pharmaceutical development, genetics, bioinformatics, ophthalmology, and eye health; downloadable computer software for providing medical or health evaluations; downloadable computer software for providing disease assessment and treatment; downloadable computer software for providing medical or health assessment; downloadable computer software for evaluation and health recommendations based on genetic, genomic, imaging, and clinical data; downloadable computer software for ophthalmological testing or screening; downloadable computer software for glaucoma testing or screeningSECTION 70 - CANCELLED—
044Medical testing and medical clinical diagnostics, namely, medical and diagnostic testing services for risk assessment, screening, diagnosis and treatment of disease; ophthalmological testing; genetic testing and screening for medical purposes; medical testing, screening and analysis services utilising an on-line portal; medical testing, screening and analysis services utilising input of genetic and clinical data via an on-line portal or paper referral; medical genetic analysis services, in particular, genome mapping, genome analysis, and genome scanning; medical genetic diagnostic testing, screening and reporting services; medical diagnostic testing, screening and reporting services; medical testing services, namely, medical testing and reporting services relating to the screening, diagnosis and treatment of disease; medical health advisory services; eye health advisory services; medical health assessment services; advisory services relating to eye health; eye health screening; glaucoma testing and screeningSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 6, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 26, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 2, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 2, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 15, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 23, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 20, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 24, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 24, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 28, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2023DOCKASSIGNED TO EXAMINER—
Aug 30, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance